Paul Tudor Jones Natera, Inc. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Natera, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 2,500 shares of NTRA stock, worth $471,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 1,600
56.25%
Holding current value
$471,500
Previous $226,000
86.73%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NTRA
# of Institutions
709Shares Held
124MCall Options Held
590KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.39 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$2.3 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.39 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.28 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$909 Million3.66% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $18.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...